首页> 美国卫生研究院文献>Journal of Clinical Biochemistry and Nutrition >Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1
【2h】

Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1

机译:性别差异:在处理血清对氧磷酶-1的流行病学和临床研究中要考虑的重要问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to evaluate the influence of sex on serum paraoxonase-1 (PON1) activities and on its relationship with cardiovascular disease risk factors such as overall and central obesity. Arylesterase and lactonase activities of PON1 were assessed in 374 women and 92 men. Both arylesterase and lactonase activities were significantly higher in women compared to men (p<0.001), irrespectively of confounders such as high density lipoprotein-cholesterol, age, smoking and body mass index or waist circumference. Sex also strongly influenced the interplay between PON1 and both fat measures, with only the arylesterase showing a significant and independent inverse correlation with the former parameter (r = −0.248, p<0.001) and the risk of overall obesity (odds ratio: 0.559, 95% confidence interval: 0.340–0.919) in women, but not in men; conversely, neither of the two activities remained associated with waist circumference in men or women after full adjustment. Noteworthy, the association between arylesterase and BMI in the female subsample was significant among women younger than forty-five years (r = −0.453, p<0.001, R2 = 0.207). In conclusion, our study suggests that sex might chiefly influence PON1 activity and its contribution to cardiovascular disease risk. Further studies are needed to confirm and clarify our preliminary findings.
机译:这项研究的目的是评估性别对血清对氧磷酶-1(PON1)活性的影响及其与心血管疾病危险因素(如整体和中枢性肥胖)的关系。在374名女性和92名男性中评估了PON1的芳基酯酶和内酯酶活性。与男性相比,女性的芳基酯酶和内酯酶活性均显着较高(p <0.001),而与诸如高密度脂蛋白胆固醇,年龄,吸烟和体重指数或腰围等混杂因素无关。性别也极大地影响了PON1与两种脂肪测量之间的相互作用,只有芳基酯酶与前一个参数(r = −0.248,p <0.001)和整体肥胖的风险(比值比:0.559, 95%的置信区间:0.340–0.919),但女性没有;相反,完全调整后,男性或女性的两项活动均与腰围无关。值得注意的是,女性亚样本中的芳基酯酶与BMI之间的关联在四十五岁以下的女性中具有显着性(r = −0.453,p <0.001,R 2 = 0.207)。总之,我们的研究表明,性别可能主要影响PON1活性及其对心血管疾病风险的影响。需要进一步研究以确认和澄清我们的初步发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号